Financial Consulate, Inc Danaher Corp Transaction History

Financial Consulate, Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$239.75 - $277.0 $15,104 - $17,451	63 Added 1.8%	3,560 $897,000
Q4 2022 Jan 11, 2023	BUY	$241.42 - $282.29 $14,485 - $16,937	60 Added 1.75%	3,497 $0
Q3 2022 Oct 20, 2022	BUY	$247.06 - $1507.4 $18,035 - $110,040	73 Added 2.17%	3,437 $888,000
Q2 2022 Jul 19, 2022	BUY	$237.11 - $299.66 $90,101 - $113,870	380 Added 12.73%	3,364 $853,000
Q1 2022 Apr 28, 2022	BUY	$257.27 - $315.76 $15,693 - $19,261	61 Added 2.09%	2,984 $875,000
Q4 2021 Feb 07, 2022	SELL	$292.08 - $329.01 $4,381 - $4,935	-15 Reduced 0.51%	2,923 $962,000
Q3 2021 Oct 19, 2021	BUY	$272.21 - $332.43 $50,358 - $61,499	185 Added 6.72%	2,938 $895,000
Q2 2021 Jul 22, 2021	SELL	$225.08 - $271.69 $135,048 - $163,014	-600 Reduced 17.89%	2,753 $739,000
Q1 2021 Apr 19, 2021	BUY	$212.38 - $245.9 $53,519 - $61,966	252 Added 8.13%	3,353 $755,000
Q4 2020 Jan 29, 2021	BUY	$212.5 - $245.46 $61,837 - $71,428	291 Added 10.36%	3,101 $689,000
Q3 2020 Oct 20, 2020	BUY	$177.16 - $215.33 $51,376 - $62,445	290 Added 11.51%	2,810 $605,000
Q2 2020 Jul 22, 2020	BUY	$128.7 - $176.83 $65,250 - $89,652	507 Added 25.19%	2,520 $446,000
Q1 2020 Apr 29, 2020	BUY	$121.39 - $169.05 $12,139 - $16,905	100 Added 5.23%	2,013 $279,000
Q1 2019 May 01, 2019	BUY	$97.62 - $132.29 $186,747 - $253,070	1,913 New	1,913 $253,000
Q4 2018 Jan 25, 2019	SELL	$94.85 - $109.54 $181,448 - $209,550	-1,913 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$98.13 - $108.9 $187,722 - $208,325	1,913 New	1,913 $208,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.